086040 — Biotoxtech Co Balance Sheet
0.000.00%
- KR₩49bn
- KR₩86bn
- KR₩41bn
Annual balance sheet for Biotoxtech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 20,612 | 27,592 | 28,212 | 31,479 | 20,384 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,977 | 8,631 | 10,261 | 8,678 | 10,096 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 27,178 | 37,746 | 49,130 | 64,692 | 58,918 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 22,055 | 25,409 | 58,066 | 58,181 | 56,516 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 63,655 | 90,741 | 125,700 | 147,036 | 136,191 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 25,718 | 45,777 | 59,528 | 75,119 | 82,210 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 30,129 | 49,597 | 81,465 | 95,326 | 96,109 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 33,526 | 41,144 | 44,235 | 51,710 | 40,082 |
Total Liabilities & Shareholders' Equity | 63,655 | 90,741 | 125,700 | 147,036 | 136,191 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |